Migrén: vizsgálatok itt: Finnország
1 trial · From EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleThe Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig)
- Where
- Helsinki
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Oslo University Hospital HF
See details and how to join2024-517981-40-00 · EU 2024-517981-40-00